全文获取类型
收费全文 | 16954篇 |
免费 | 1530篇 |
国内免费 | 1338篇 |
专业分类
19822篇 |
出版年
2024年 | 45篇 |
2023年 | 235篇 |
2022年 | 490篇 |
2021年 | 777篇 |
2020年 | 640篇 |
2019年 | 730篇 |
2018年 | 729篇 |
2017年 | 518篇 |
2016年 | 727篇 |
2015年 | 1073篇 |
2014年 | 1293篇 |
2013年 | 1325篇 |
2012年 | 1532篇 |
2011年 | 1366篇 |
2010年 | 933篇 |
2009年 | 779篇 |
2008年 | 833篇 |
2007年 | 776篇 |
2006年 | 742篇 |
2005年 | 619篇 |
2004年 | 558篇 |
2003年 | 559篇 |
2002年 | 458篇 |
2001年 | 259篇 |
2000年 | 220篇 |
1999年 | 222篇 |
1998年 | 156篇 |
1997年 | 124篇 |
1996年 | 122篇 |
1995年 | 121篇 |
1994年 | 106篇 |
1993年 | 76篇 |
1992年 | 96篇 |
1991年 | 76篇 |
1990年 | 75篇 |
1989年 | 51篇 |
1988年 | 38篇 |
1987年 | 35篇 |
1986年 | 41篇 |
1985年 | 30篇 |
1984年 | 22篇 |
1983年 | 11篇 |
1982年 | 16篇 |
1981年 | 27篇 |
1980年 | 14篇 |
1974年 | 14篇 |
1973年 | 11篇 |
1972年 | 13篇 |
1969年 | 10篇 |
1963年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
DMD/BMD缺失基因的检测及其表达产物的变化 总被引:1,自引:0,他引:1
目的:检测Duchenne/Becker型肌营养不良症(DMD/BMD)患者基因缺失及其表达产物--抗肌营养不良蛋白在肌细胞中的变化,探讨其与临床病情的关系.方法:应用9对引物多重PCR技术对42例DMD/BMD患者进行基因检测;并采用免疫荧光抗体染色技术对5例DMD,2例BMD肌细胞膜上抗肌营养不良蛋白的表达观察分析,以2例正常人的肌组织作为对照.结果:共发现21例外显子缺失,缺失片段长度各异,其中16例(76.2%)累及中央缺失热区,5例(23.8%)位于5'端缺失热区,尤以48号外显子缺失频率最高.5例DMD患者胞膜抗肌营养不良蛋白染色阴性,其中1例未检出基因缺失,但抗肌营养不良蛋白无表达.2例BMD患者染色弱阳性,可见间断斑片状荧光带.结论:DMD/BMD病情轻重可能与基因缺失的数量和片段大小不呈平行关系,而是与外显子的缺失类型有密切关系;基因的表达受个体差异的影响,呈高度的遗传异质性.抗肌营养不良蛋白缺乏或表达异常是造成DMD/BMD表型的病理基础,其临床后果不仅取决于缺失程度,还取决于缺失区域的功能意义. 相似文献
993.
994.
995.
用呼吸道合胞病毒R6(武汉地方株)活毒滴鼻加用戍二醛固定的病毒感染的Hela细胞免疫BALB/C鼠,取脾细胞与小鼠骨髓瘤SP_2/0细胞融合,培育出分泌抗呼吸道合胞病毒单克隆抗体的杂交瘤细胞13株,这些细胞的染色体数为94至104条,其分泌的抗体分别属于鼠IgC_1、IgG_(2a)、IgG_(2b)亚类。腹水荧光抗体滴度为1:10000~1:100000。其中五株单抗有中和病毒作用,尤其是两株中和放价达1:128。应用免疫转印法证实了这些单抗分别能识别RSV6种主要结构蛋白,用7株识别不同病毒结构蛋白的单抗对12株合胞病毒进行抗原性分析,可将这些病毒区分为二个血清型,即A亚型和B亚型。 相似文献
996.
Wenguo Fan Fang Huang Weiguo Dong Zhixiong Gao Cuixia Li Xiao Zhu Dongpei Li Hongwen He 《Journal of molecular histology》2009,40(3):209-215
Heme oxygenase (HO)/carbon monoxide (CO) and nitric oxide synthase (NOS)/nitric oxide (NO) systems are involved in sensory
information processing. The present study was undertaken to examine the distribution of HO-2 and NOS in the spinal trigeminal
nucleus (STN) of the rat, using histochemistry and immunohistochemistry. Nicotinamide adenine dinucleotide phosphate-diaphorase
(NADPH-d) staining was found that NADPH-d activity was more prominent in the nucleus caudalis (Vc) and the dorsomedial subdivision
of the nucleus oralis (Vo) than in other spinal trigeminal regions. Immunohistochemistry for HO-2 revealed that HO-2 staining
neurons distributed extensively, which intensity was higher in the rostral than caudal part of the STN. The colocalization
of NADPH-d and HO-2 was mainly confined in the Vc. The expression and distribution of NADPH-d and HO-2 suggest that NO and
CO are likely neurotransmitters and might function in the processing orofacial signal in the STN together. 相似文献
997.
Copy-Number Mutations on Chromosome 17q24.2-q24.3 in Congenital Generalized Hypertrichosis Terminalis with or without Gingival Hyperplasia 总被引:1,自引:0,他引:1
Miao Sun Ning Li Wu Dong Qing Liu Guang He Xin Li Yang Luo Dan Lv Dai Zhang Chaoxia Lu Lihua Cao W.H. Irwin McLean Ming-Rong Wang Lin He Wilson H.Y. Lo 《American journal of human genetics》2009,84(6):807-813
Congenital generalized hypertrichosis terminalis (CGHT) is a rare condition characterized by universal excessive growth of pigmented terminal hairs and often accompanied with gingival hyperplasia. In the present study, we describe three Han Chinese families with autosomal-dominant CGHT and a sporadic case with extreme CGHT and gingival hyperplasia. We first did a genome-wide linkage scan in a large four-generation family. Our parametric multipoint linkage analysis revealed a genetic locus for CGHT on chromosome 17q24.2-q24.3. Further two-point linkage and haplotyping with microsatellite markers from the same chromosome region confirmed the genetic mapping and showed in all the families a microdeletion within the critical region that was present in all affected individuals but not in unaffected family members. We then carried out copy-number analysis with the Affymetrix Genome-Wide Human SNP Array 6.0 and detected genomic microdeletions of different sizes and with different breakpoints in the three families. We validated these microdeletions by real-time quantitative PCR and confirmed their perfect cosegregation with the disease phenotype in the three families. In the sporadic case, however, we found a de novo microduplication. Two-color interphase FISH analysis demonstrated that the duplication was inverted. These copy-number variations (CNVs) shared a common genomic region in which CNV is not reported in the public database and was not detected in our 434 unrelated Han Chinese normal controls. Thus, pathogenic copy-number mutations on 17q24.2-q24.3 are responsible for CGHT with or without gingival hyperplasia. Our work identifies CGHT as a genomic disorder. 相似文献
998.
Lequn Zhao Hongyun Dong Cheng Cheng Zhang Lisa Kinch Mitsujiro Osawa Michelina Iacovino Nikolai V. Grishin Michael Kyba Lily Jun-shen Huang 《The Journal of biological chemistry》2009,284(39):26988-26998
JAK2 (Janus kinase 2) is essential for cytokine receptor signaling, and several lines of evidence support a causal role of an activating JAK2 mutation in myeloproliferative disorders. JAK2 activity is autoinhibited by its pseudokinase domain in the basal state, and the inhibition is released by cytokine stimulation; how engagement of the cognate receptor triggers this release is unknown. From a functional screen for gain-of-function JAK2 mutations, we discovered 13 missense mutations, nine in the pseudokinase domain and four in the Src homology 2 (SH2)-pseudokinase domain linker. These mutations identified determinants for autoinhibition and inducible activation in JAK2. Two of the mutants, K539I and N622I, resulted in erythrocytosis in mice. Scanning mutagenesis of the SH2-pseudokinase domain linker indicated that its N-terminal part was essential for interaction of JAK2 with the Epo receptor, whereas certain mutations in the C-terminal region conferred constitutive activation. We further showed that substitutions for Glu543-Asp544 in this linker or Leu611, Arg683, or Phe694 in the hinge proximal region of the pseudokinase domain resulted in activated JAK2 mutants that could not be further stimulated by Epo. These results suggest that the SH2-pseudokinase domain linker acts as a switch that relays cytokine engagement to JAK2 activation by flexing the pseudokinase domain hinge.The Janus family of tyrosine kinases (JAKs)2 are key regulators of cytokine receptor signaling in hematopoiesis and immune responses (1). Of the four mammalian JAK kinases, JAK2 transmits signals for a variety of cytokine receptors, including the erythropoietin receptor (EpoR) that is essential for red blood cell production (2). Upon Epo stimulation, JAK2 activates downstream signaling, such as STAT5, Ras/mitogen-activated protein kinase, and phosphatidylinositol 3-kinase/AKT pathways (2). Mice deficient in Epo, EpoR, or JAK2 die embryonically due to the absence of definitive erythropoiesis (3–5).In addition to regulation by phosphatases and suppressors of cytokine signaling (6, 7), JAK2 kinase activity is critically controlled by an autoinhibitory mechanism. Like other JAK members, JAK2 contains an N-terminal segment followed by a pseudokinase domain and a C-terminal tyrosine kinase domain. The N-terminal segment, consisting of a FERM (protein 4.1, ezrin, moezin, radixin homologous) domain and an atypical SH2 domain (1), mediates association with the membrane-proximal region of the cytokine receptors (8). Binding of JAK2 through its N-terminal segment to the EpoR is essential for EpoR surface expression (9). The pseudokinase domain is predicted to adopt a kinase fold but lacks residues essential for catalysis (10). Deletion of the pseudokinase domain leads to a marked increase in JAK2 kinase activity and loss of response to cytokine stimulation (11–13). Therefore, this domain is essential for JAK2 autoinhibition and is essential for JAK2 activation upon cytokine stimulation. Consistent with this notion, a point mutation in the JAK2 pseudokinase domain was identified in the majority of myeloproliferative disorder patients, including 90% of polycythemia vera (PV) patients (14–18). This mutation, V617F, in the presence of a dimerized receptor scaffold, such as the EpoR, resulted in the constitutive activation of JAK2 and downstream signaling effectors (19, 20) and caused erythrocytosis in a murine bone marrow transplant model (14, 21–23). Recently, mutations immediately adjacent to the JAK2 pseudokinase domain in the SH2-pseudokinase domain linker were identified in PV patients and shown to cause constitutive activation of JAK2 and a PV-like phenotype in mice (24–26). The molecular mechanisms underlying the control of JAK2 activity (i.e. the swift augmentation of its activity upon receptor activation) are poorly understood. The residues involved in the autoinhibition in JAK2 are unknown.In this work, we sought to characterize the regulatory mechanisms controlling JAK2 kinase activity. Using a functional screen for activating JAK2 mutations that signal constitutively, we discovered 13 mutations in the pseudokinase domain and in the SH2-pseudokinase domain linker. These mutations identified specific residues that are important for the inhibition of basal JAK2 kinase activity and for cytokine-induced JAK2 activation. In addition, we showed that the SH2-pseudokinase domain linker is essential for interaction with the EpoR, autoinhibitory regulation, and Epo-inducible JAK2 activation and may act as a switch in relaying cytokine receptor engagement to JAK2 activation by flexing the pseudokinase domain hinge. 相似文献
999.
This present study was undertaken to investigate whether arsenic exposure increases the risk of children’s low intelligence quotient (IQ) in China. MEDLINE, SCI, CNKI, and CBM search were organized for all documents published, in English and Chinese, between 1988 and 2008 using the following keywords: arsenic, intelligence, and IQ. As a result, four cross-sectional studies that assessed the development of low IQ in children who had been exposed to arsenic earlier in their life were included in this study. The summary weighted mean difference of IQ was calculated in this meta-analyses, when arsenicosis areas or slight arsenicosis areas were compared with non-arsenicosis areas; it is ?6.85 (95% confidence interval [CI]?=??8.30 to ?5.41; p?<?0.01, using a fixed effect model) and ?6.54 (95%CI?=??8.93 to ?4.15; p?<?0.01, using a random effect model), which means that children who live in an arsenicosis area or a slight arsenicosis area have lower IQ than those who live in a non-arsenicosis area, and there may be a strong association between arsenic and children’s intelligence. 相似文献
1000.